The potential use of enamel matrix derivative for In situ anterior cruciate ligament tissue engineering: A translational In vitro investigation

Tissue Engineering

Volumn 13, Issue 8, 2007, Pages 2041-2051

  Messenger, Michael P ^a   Raif, El Mustafa ^a   Seedhom, Bahaa B ^a   Brookes, Steven J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTERIOR CRUCIATE LIGAMENT (ACL); ENAMEL MATRIX DERIVATIVE (EMD); TISSUE INFILTRATION;

ABRASION; CELLS; POLYMERS; TISSUE ENGINEERING;

SCAFFOLDS;

BIOMATERIAL; DNA; ENAMEL MATRIX DERIVATIVE; POLYETHYLENE TEREPHTHALATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTERIOR CRUCIATE LIGAMENT; ARTICLE; CATTLE; CELL ADHESION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DNA CONTENT; ENAMEL; IN VITRO STUDY; LIGAMENT SURGERY; NONHUMAN; PRIORITY JOURNAL; SYNOVIOCYTE; TISSUE ENGINEERING; TISSUE REPAIR;

ANIMALS; ANTERIOR CRUCIATE LIGAMENT; CATTLE; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELLS, CULTURED; DENTAL ENAMEL PROTEINS; SYNOVIAL MEMBRANE; TISSUE ENGINEERING;

ANIMALIA; BOVINAE;

EID: 34548076883     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2006.0059     Document Type: Article

References (60)

1. Irrgang, J., Safran, M., and Fu, F.H., The knee: ligamentous and meniscal injuries. In: Zachazewski, J., Magee, D., and Quillen, W., Eds. Athletic Injuries and Rehabilitation. Philadelphia, PA: Saunders, 1996, pp. 623-692.
2. Murphy, P.G., Frank, C.B., and Hart, D.A., The cell biology of ligaments and ligament healing. In: Jackson, D.W., Ed. The Anterior Cruciate Ligament: Current and Future Concepts. New York, Raven: 1993, pp. 165.
3. Cameron, M. and Fu, F.H., Prosthetic ligaments in ACL reconstruction. Bull Rheum Dis 43, 4, 1994.
4. Herrington, L., et al. Anterior cruciate ligament reconstruction, hamstring versus bone-patella tendon-bone grafts: a systematic literature review of outcome from surgery. Knee 12, 41, 2005.
5. Arnoczky, S.P., Tarvin, G.B., and Marshall, J.L., Anterior cruciate ligament replacement using patellar tendon. An evaluation of graft revascularization in the dog. J Bone Joint Surg Am 64, 217, 1982.
6. Amiel, D., et al. The phenomenon of "ligamentization": anterior cruciate ligament reconstruction with autogenous patellar tendon. J Orthop Res 4, 162, 1986.
7. Delay, B.S., McGrath, B.E., and Mindell, E.R., Observations on a retrieved patellar tendon autograft used to reconstruct the anterior cruciate ligament: a case report. J Bone Joint Surg Am 84, 1433, 2002.
8. Tohyama, H. and Yasuda, K., Extrinsic cell infiltration and revascularization accelerate mechanical deterioration of the patellar tendon after fibroblast necrosis. J Biomech Eng 122, 594, 2000.
9. Barber, F.A., Should allografts be used for routine anterior cruciate ligament reconstructions? Arthroscopy 19, 421, 2003.
10. Fujikawa, K., et al. Anterior cruciate ligament reconstruction with the Leeds-Keio artificial ligament. J Long Term Eff Med Implants 10, 225, 2000.
11. Matsumoto, H. and Fujikawa, K. Leeds-Keio artificial ligament: a new concept for the anterior cruciate ligament reconstruction of the knee. Keio J Med 50, 161, 2001.
12. Lettry, S., Roccavilla, F., and Seedhom, B. Abrasion of artificial ligaments: a simulative study. J Orthop Sci 5, 481, 2000.
13. Fujikawa, K., et al. The Leeds-Keio ligament. In: Strover, A., Ed. Intra-articular Reconstruction of the Anterior Cruciate Ligament. London: Butterworth Heinemann, 1993, pp. 173-207.
14. Rowland, J.R., et al. Radiofrequency-generated glow discharge treatment: potential benefits for polyester ligaments. J Orthop Sci 8, 198, 2003.
15. Tsukazaki, S., et al. Comparative study of the covered area of Leeds-Keio (LK) artificial ligament and radio frequency generated glow discharge treated Leeds-Keio (Bio-LK) ligament with synovial cells. J Long Term Eff Med Implants 13, 355, 2003.
16. Molloy, T., Wang, Y., and Murrell, G. The roles of growth factors in tendon and ligament healing. Sports Med 33, 381, 2003.
17. Kondo, E., et al. Effects of administration of exogenous growth factors on biomechanical properties of the elongation-type anterior cruciate ligament injury with partial laceration. Am J Sports Med 33, 188, 2005.
18. Nagumo, A., et al. Effects of separate application of three growth factors (TGF-beta1, EGF, and PDGF-BB) on mechanical properties of the in situ frozen-thawed anterior cruciate ligament. Clin Biomech (Bristol, Avon) 20, 283, 2005.
19. Okuizumi, T., et al. The effect of cell-based therapy with autologous synovial fibroblasts activated by exogenous TGF-beta1 on the in situ frozen-thawed anterior cruciate ligament. J Orthop Sci 9, 488, 2004.
20. Yasuda, K., et al. The effect of growth factors on biomechanical properties of the bone-patellar tendon-bone graft after anterior cruciate ligament reconstruction: a canine model study. Am J Sports Med 32, 870, 2004.
21. Azuma, H., et al. Timing of administration of transforming growth factor-beta and epidermal growth factor influences the effect on material properties of the in situ frozen-thawed anterior cruciate ligament. J Biomech 36, 373, 2003.
22. Sakai, T., et al. Effects of combined administration of transforming growth factor-beta1 and epidermal growth factor on properties of the in situ frozen anterior cruciate ligament in rabbits. J Orthop Res 20, 1345, 2002.
23. Mi, Z., et al. Adverse effects of adenovirus-mediated gene transfer of human transforming growth factor beta 1 into rabbit knees. Arthritis Res Ther 5, R132, 2003.
24. Border, W.A. and Noble, N.A., Transforming growth factor beta in tissue fibrosis. N Engl J Med 331, 1286, 1994.
25. Heijl, L., et al. Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects. J Clin Periodontal 24, 705, 1997.
26. Lyngstadaas, S.P., et al. Autocrine growth factors in human periodontal ligament cells cultured on enamel matrix derivative. J Clin Periodontal 28, 181, 2001.
27. Hammarstrom, L. Enamel matrix, cementum development and regeneration. 24, 658, 1997.
28. Kalpidis, C.D. and Ruben, M.P., Treatment of intrabony periodontal defects with enamel matrix derivative: a literature review. J Periodontal 73, 1360, 2002.
29. Zetterstrom, O., et al. Clinical safety of enamel matrix derivative (EMDOGAIN) in the treatment of periodontal defects. J Clin Periodontal 24, 697, 1997.
30. Zeichner-David, M. Is there more to enamel matrix proteins than biomineralization? Matrix Biol 20, 307, 2001.
31. Davenport, D.R., et al. Effects of enamel matrix protein application on the viability, proliferation, and attachment of human periodontal ligament fibroblasts to diseased root surfaces in vitro. J Clin Periodontal 30, 125, 2003.
32. van der Pauw, M.T.M., et al. Enamel matrix-derived protein stimulates attachment of periodontal ligament fibroblasts and enhances alkaline phosphatase activity and transforming growth factor beta 1 release of periodontal ligament and gingival fibroblasts. J Periodontal 71, 31, 2000.
33. Suzuki, N., et al. Attachment of human periodontal ligament cells to enamel matrix-derived protein is mediated via interaction between BSP-like molecules and integrin alpha V beta 3. J Periodontal 72, 1520, 2001.
34. Hoang, A.M., et al. Amelogenin is a cell adhesion protein. J Dent Res 81, 497, 2002.
35. Suzuki, S., et al. Enamel matrix derivative gel stimulates signal transduction of BMP and TGF-beta. J Dent Res 84, 510, 2005.
36. Yoneda, S., et al. The effects of enamel matrix derivative (EMD) on osteoblastic cells in culture and bone regeneration in a rat skull defect. J Periodontal Res 38, 333, 2003.
37. Schwartz, Z., et al. Porcine fetal enamel matrix derivative stimulates proliferation but not differentiation of pre-osteoblastic 2T9 cells, inhibits proliferation and stimulates differentiation of osteoblast-like MG63 cells, and increases proliferation and differentiation of normal human osteoblast NHOst cells. J Periodontal 71, 1287, 2000.
38. Palioto, D.B., et al. The influence of enamel matrix derivative associated with insulin-like growth factor-I on periodontal ligament fibroblasts. J Periodontol 75, 498, 2004.
39. Okubo, K., et al. Participation of endogenous IGF-I and TGF-beta 1 with enamel matrix derivative-stimulated cell growth in human periodontal ligament cells. J Periodontal Res 38, 1, 2003.
40. Kawase, T., et al. Anti-TGF-beta antibody blocks enamel matrix derivative-induced upregulation of p21WAF1/cip1 and prevents its inhibition of human oral epithelial cell proliferation. J Periodontal Res 37, 255, 2002.
41. Kawase, T., et al. Enamel matrix derivative (EMDOGAIN) rapidly stimulates phosphorylation of the MAP kinase family and nuclear accumulation of smad2 in both oral epithelial and fibroblastic human cells. J Periodontal Res 36, 367, 2001.
42. Jiang, J., et al. Effects of enamel matrix derivative on gene expression of primary osteoblasts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91, 95, 2001.
43. He, J., et al. Emdogain promotes osteoblast proliferation and differentiation and stimulates osteoprotegerin expression. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97, 239, 2004.
44. Haase, H.R. and Bartold, P.M., Enamel matrix derivative induces matrix synthesis by cultured human periodontal fibroblast cells. J Periodontol 72, 341, 2001.
45. Veis, A., Amelogenin gene splice products: potential signaling molecules. Cell Mol Life Sci 60, 38, 2003.
46. Veis, A., et al. Specific amelogenin gene splice products have signaling effects on cells in culture and in implants in vivo. J. Biol. Chem 275, 41263, 2000.
47. Hoang, A.M., Oates, T.W., and Cochran, D.L. In vitro wound healing responses to enamel matrix derivative. J Periodontol 71, 1270, 2000.
48. Gestrelius, S., et al. In vitro studies on periodontal ligament cells and enamel matrix derivative. J Clin Periodontol 24, 685, 1997.
49. Nikolopoulos, S., Peteinaki, E., and Castanas, E., Immunologic effects of emdogain in humans: one-year results. Int J Periodontics Restorative Dent 22, 269, 2002.
50. Raif, E.M. and Seedhom, B.B. Effect of cyclic tensile strain on proliferation of synovial cells seeded onto synthetic ligament scaffolds - an in vitro simulation. Bone 36, 433, 2005.
51. De Bari, C., et al. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44, 1928, 2001.
52. Hoemann, C.D., et al. A multivalent assay to detect glycosaminoglycan, protein, collagen, RNA, and DNA content in milligram samples of cartilage or hydrogel-based repair cartilage. Anal Biochem 300, 1, 2002.
53. Gestrelius, S., et al. Formulation of enamel matrix derivative for surface coating. Kinetics and cell colonization. J Clin Periodontol 24, 678, 1997.
54. Laemmli, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680, 1970.
55. Djouad, F., et al. Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells. Arthritis Res Ther 7, R1304, 2005.
56. Van Eijk, F., et al. Tissue engineering of ligaments: a comparison of bone marrow stromal cells, anterior cruciate ligament, and skin fibroblasts as cell source. Tissue Eng 10, 893, 2004.
57. Ge, Z., Goh, J.C., and Lee, E.H., Selection of cell source for ligament tissue engineering. Cell Transplant 14, 573, 2005.
58. Ohyama, M., et al. Effect of enamel matrix derivative on the differentiation of C2C12 cells. J Periodontol 73, 543, 2002.
59. van der Pauw, M.T., Everts, V., and Beertsen, W., Expression of integrins by human periodontal ligament and gingival fibroblasts and their involvement in fibroblast adhesion to enamel matrix-derived proteins. J Periodontal Res 37, 317, 2002.
60. Keila, S., et al. In vitro effects of enamel matrix proteins on rat bone marrow cells and gingival fibroblasts. J Dent Res 83, 134, 2004.